Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients.
about
Sulodexide therapy for the treatment of diabetic nephropathy, a meta-analysis and literature reviewTherapeutic Modalities in Diabetic Nephropathy: Future Approaches.Characterization of anticoagulant heparinoids by immunoprofiling.Sulodexide decreases albuminuria and regulates matrix protein accumulation in C57BL/6 mice with streptozotocin-induced type I diabetic nephropathyAnti-proteinuric effect of sulodexide in immunoglobulin a nephropathy.Effect of sulodexide on urinary biomarkers of kidney injury in normoalbuminuric type 2 diabetes: a randomized controlled trial.Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy.Use of low-dose sulodexide in IgA nephropathy patients on renin-angiotensin system blockadesPreclinical and clinical evidence of nephro- and cardiovascular protective effects of glycosaminoglycans.Pathophysiology of the diabetic kidney.Diabetic nephropathy: landmark clinical trials and tribulations.Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsideredPrevention of recurrent deep venous thrombosis with sulodexide: the SanVal registry.Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy.
P2860
Q28083781-CAB51FB1-C771-471A-871D-C491AE77C672Q30423005-870F1CBC-D110-42CC-905E-CE873EB474AAQ33376879-918C5A82-69D7-475B-98BC-FAD0AEF58457Q34563204-1197BB01-FD45-48A4-9A09-9718AFE7CD1BQ35014833-08680B45-7CC1-412C-B2FB-DB5A14BC4F7FQ35412466-ABC9DBB0-18B7-49AD-A5F3-021596F91E0AQ35720773-A9EBF2B1-066A-4833-8FBE-7D0A3B8A4691Q36471767-F1827DAE-5FAF-49A8-9279-0882D1C8F96DQ37988853-6402E8E3-900A-4A70-A66B-D946D8A3A4FBQ38111707-6C86B8D0-6CDF-425C-BF34-F144E94C80FCQ38338539-97A3FCCD-11CC-487E-9297-5A09FB3CB00DQ42490341-534923A3-FEF6-436B-B50E-597482DF6E23Q44905222-85900072-E1A1-42C9-81C7-01A7163A1A69Q46935445-CCA65957-ACD2-466A-B803-EC11DAE4B475
P2860
Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients.
description
1997 nî lūn-bûn
@nan
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients.
@ast
Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients.
@en
Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients.
@nl
type
label
Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients.
@ast
Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients.
@en
Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients.
@nl
prefLabel
Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients.
@ast
Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients.
@en
Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients.
@nl
P2093
P1476
Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients.
@en
P2093
P356
10.1016/S0168-8227(97)00076-4
P577
1997-10-01T00:00:00Z